Christopher P. Scally

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

8

H-Index

1

About

Dr. Christopher P. Scally is a leading surgical oncologist whose research focuses on the operative management of gastrointestinal malignancies, particularly gastric and duodenal gastrointestinal stromal tumors (GISTs). His seminal work, "Robotic excision of gastric and duodenal gastrointestinal stromal tumor" (2022), has garnered 8 citations, establishing a benchmark for minimally invasive approaches in complex GIST resections. Dr. Scally’s contributions center on refining robotic surgical techniques to improve patient outcomes, reduce recovery times, and expand the boundaries of what is achievable in oncologic surgery. Beyond this highly cited paper, his broader portfolio investigates the intersection of surgical innovation and oncologic safety, influencing both clinical practice and surgical training. His work is recognized for its technical precision and translational impact, offering a roadmap for surgeons adopting robotic platforms in the management of rare tumors. Dr. Scally’s dedication to advancing surgical oncology through evidence-based, patient-centered research makes him a valuable resource for students and researchers interested in the future of robotic surgery and gastrointestinal cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robotic excision of gastric and duodenal gastrointestinal stromal tumor
8 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago